ПЛЕНАРНЫЕ ДОКЛАДЫ
Kian Fan Chung Imperial College, London, UK; Faculty of Medicine, National Heart & Lung Institute
Personalised medicine for severe asthma
Rudolf Valenta Department of Pathophysiology and Allergy Research, Center of Pathophysiology, Infectiology & Immunology, Medical University Vienna, Austria
New aspects of birch pollen allergy
Bryan L. Martin The Ohio State University in Columbus, Ohio, USA
Asthma COPD overlap
Todor A. Popov University Hospital “Sv. Ivan Rilski”, Sofia, Bulgaria
Evolution of allergic rhinitis management: a spiral of sophistication
Sami Bahna Allergy & Immunology Section, Louisiana State University Health Sciences Center, Shreveport, USA
Should peanut be banned from schools?
Giovanni Passalacqua Allergy and Respiratory Diseases Dept, Specialty School in Respiratory Diseases, University of Genoa, Italy
Biologicals for severe asthma in real life
Kamal Maurice Hanna Faculty of Medicine, Cairo University, Cairo, Egypt
Anaphylaxis: Phenotypes and endotypes
Elias Toubi Faculty of Medicine, Technion, Haifa, Israel
Seasonal exacerbation of asthma is frequently associated with recurrent episodes of acute urticarial
Kamal Maurice Hanna Faculty of Medicine, Cairo University, Cairo, Egypt
Biomarkers and biologics for asthma management
Cezmi Akdis SIAF, University Zurich, Switzerland
Mechanisms of how microbiome regulates inflammation
С.М. Деев Институт биоорганической химии им. М.М. Шемякина и Ю.А. Овчинникова РАН, Москва, Россия
Рациональный дизайн иммунотаргетных препаратов
Mübeccel Akdis Swiss Institute of Allergy and Asthma Research (SIAF), Davos, Switzerland
A novel B cell subset that induces angiogenesis
Elias Toubi Faculty of Medicine, Technion, Haifa, Israel
Semaphorin 3A is highly beneficial in treating bronchial asthma: reducing both inflammation and angiogenesis
С.М. Деев Институт биоорганической химии им. М.М. Шемякина и Ю.А. Овчинникова РАН, Москва, Россия
«Целое больше, чем сумма составляющих частей» - гибридные наноструктуры для онкотераностики
|